 |
Dimethyl sulfoxide |
|---|---|
| Trade Name | |
| Orphan Indication | Increased intracranial pressure in patients with severe, closed-head injury, also known as traumatic brain coma, for whom no other effective treatment is available |
| USA Market Approval | USA |
| USA Designation Date | 1994-11-22 00:00:00 |
| Sponsor | Abela Pharmaceuticals, Inc.;21581 Midcrest Drive;Lake Forest, California, 92630 |
